Genesis Healthcare, Inc. GENNQ
—
0.00
0.00
NaN
as of 24 Sep
- Market cap
- —
- P/E
- 0.0×
Follow GENNQ
| Sep '21 | Jun '21 | Mar '21 | Dec '20 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.22 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.01 | 0.01 | 0.01 | 0.01 | |
P/FCF ratio |
0.14 | 0.00 | 0.12 | 0.17 | |
P/Operating CF |
(0.48) | 1.67 | (0.65) | 1.55 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.39 | 0.39 | 0.37 | 0.34 | |
EV/EBITDA |
79.52 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(31.82) | (26.96) | 5.42 | 4.21 | |
EV/FCF |
7.53 | (42.35) | 5.12 | 4.25 | |
Quick Ratio |
0.21 | 0.20 | 0.18 | 0.19 | |
Current Ratio |
0.26 | 0.25 | 0.22 | 0.23 | |
Net Debt/EBITDA |
14.72 | 26.45 | (27.33) | (17.27) | |
Debt/Assets |
49.60% | 49.75% | 41.57% | 38.79% | |
Debt/Equity |
(1.45) | (1.41) | (1.28) | (1.36) | |
Asset Turnover |
0.94 | 0.95 | 0.90 | 0.90 | |
Operating CF/Net income |
(0.88) | 0.32 | 1.51 | (4.51) | |
Capex/Depreciation |
(0.38) | (0.21) | (0.26) | 10.40 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
67.61% | 65.29% | 70.95% | 71.80% | |
Intangible Assets out of Total Assets |
0.05 | 0.05 | 0.04 | 0.04 | |
Share Based Compensation of Revenue |
0.05% | 0.13% | 0.21% | 0.13% | |
Graham Net Nets |
(138.53) | (92.91) | (130.48) | (81.12) | |
Graham Number |
0.00 | 7.84 | 17.99 | 11.90 | |
Earnings Yield |
459.80% | (91.22%) | (483.36%) | (126.10%) | |
Free Cash Flow Yield |
730.96% | (85.58%) | 835.14% | 581.72% | |
Revenue per Share |
6.38 | 6.84 | 7.88 | 8.22 | |
Operating CF per Share |
(0.42) | 0.19 | (0.43) | 0.31 | |
Capex per Share |
(0.06) | (0.07) | (0.10) | 2.20 | |
Free Cash Flow per Share |
(0.48) | 0.12 | (0.53) | 2.51 | |
Cash per Share |
1.57 | 1.94 | 1.98 | 2.70 | |
Shareholders Equity per Share |
(8.56) | (9.36) | (10.63) | (10.39) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(8.56) | (9.36) | (10.63) | (10.39) | |
Free Cash Flow |
(57.98) | 14.02 | (60.17) | 280.51 | |
Working Capital |
(2,025.69) | (2,201.32) | (2,809.35) | (2,975.58) | |
Capital Expenditures |
(7.81) | (8.76) | (11.23) | 245.94 | |
Net Current Asset Value |
(3,342.71) | (3,527.08) | (4,164.69) | (4,355.36) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | (0.27) | |
Net Profit Margin |
7.40% | 8.82% | (3.61%) | (0.83%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
418.32 | 412.56 | 480.75 | 497.28 | |
Average Payables |
181.53 | 200.83 | 187.93 | 224.87 | |
Average Assets |
3,612.99 | 3,759.06 | 4,117.55 | 4,362.19 | |
Average Common Equity |
(1,089.08) | (1,090.05) | (1,127.12) | (1,122.41) |
Columns are period end dates